Takeda Pharmaceutical Company Limited Cash And Cash Equivalents
Takeda Pharmaceutical Company Limited (TKPHF) had Cash And Cash Equivalents of JPY 385.11 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2025-06-25
- 2025-03-31: Cash And Cash Equivalents 385.11B JPY.
- 2024-03-31: Cash And Cash Equivalents 457.80B JPY.
- 2023-03-31: Cash And Cash Equivalents 533.53B JPY.
- 2022-03-31: Cash And Cash Equivalents 849.70B JPY.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-03-31 | 385.11B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 457.80B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 533.53B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 849.70B JPY 20-F · filed 2025-06-25 |
| 2021-03-31 | 966.22B JPY 20-F · filed 2024-06-26 |
| 2020-03-31 | 637.61B JPY 20-F · filed 2023-06-28 |
| 2019-03-31 | 702.09B JPY 20-F · filed 2022-06-29 |
| 2018-03-31 | 294.52B JPY 20-F · filed 2021-06-29 |
| 2017-03-31 | 319.45B JPY 20-F · filed 2020-06-24 |
| 2016-03-31 | 451.43B JPY 20-F · filed 2019-06-27 |